ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,767.50
0.10%
S&P ASX All Technology
3,137.90
0.55%
Brent Oil
84.85
0.00%
US Dollar vs AUD
1.49566
0.00%
Bitcoin
60,700.73
0.64%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. Legacy Healthcare Properties (LRP)

  7. Legacy Healthcare Properties (LRP) News

LRP

Legacy Healthcare Properties (LRP)

Legacy Healthcare Properties
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:LRP
DateTimeSourceHeadlineSymbolCompany
14/04/201105:30Edgar (US Regulatory)Withdrawal of Registration Statement (RW)NYSE:LRPLegacy Healthcare Properties
05/10/201021:21Edgar (US Regulatory)Securities Registration: Real Estate Company (S-11/A)NYSE:LRPLegacy Healthcare Properties
17/09/201007:30Edgar (US Regulatory)Securities Registration: Real Estate Company (S-11/A)NYSE:LRPLegacy Healthcare Properties
22/07/200805:24PR Newswire (US)/C O R R E C T I O N from Source -- Lorus Therapeutics Inc./NYSE:LRP
21/07/200821:30PR Newswire (US)Lorus Therapeutics Reports Fourth Quarter Results for Fiscal Year 2008NYSE:LRP
16/07/200822:12PR Newswire (US)Lorus Therapeutics Receives $600 Thousand From Escrow AccountNYSE:LRP
09/07/200822:00PR Newswire (US)Lorus Therapeutics Provides an Update on Progress in Virulizin(R) Development ProgramNYSE:LRP
02/07/200823:00PR Newswire (US)Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination withNYSE:LRP
23/06/200821:30PR Newswire (US)Lorus Therapeutics announces that the European Medicines Agency (EMEA) has granted the orphan drug designation to LOR-2040 for tNYSE:LRP
07/05/200806:22PR Newswire (US)AMEX Accepts Lorus' Plan to Meet AMEX's Continued Listing StandardsNYSE:LRP
05/05/200821:30PR Newswire (US)Lorus Therapeutics Strengthens Its Senior Management Team Through Internal PromotionsNYSE:LRP
22/04/200822:30PR Newswire (US)Lorus initiates development program exploring novel route of administration for LOR-2040NYSE:LRP
16/04/200822:30PR Newswire (US)Lorus Therapeutics presents new findings for the anticancer drugs LOR-253 and LOR-2040NYSE:LRP
09/04/200812:04PR Newswire (US)Lorus Therapeutics Announces Exclusive Multinational License Agreement with Zoticon Bioventures for Virulizin(R)NYSE:LRP
23/01/200810:17PR Newswire (US)Lorus Therapeutics Appoints Peter Korth as Chief Financial OfficerNYSE:LRP
06/11/200723:30PR Newswire (US)Lorus announces presentation of corporate overview at the Rodman and Renshaw Annual Healthcare ConferenceNYSE:LRP
20/09/200712:23PR Newswire (US)Lorus Therapeutics announces election of three new Directors and appoints a new ChairmanNYSE:LRP
29/08/200722:30PR Newswire (US)Lorus Advances Clinical Development of GTI-2040 Combined with Ara-C in Acute Myeloid LeukemiaNYSE:LRP
24/07/200708:48PR Newswire (US)Lorus Therapeutics Announces the Appointment of a New Member of the Board of DirectorsNYSE:LRP
11/07/200710:04PR Newswire (US)Lorus Therapeutics completes reorganization resulting in non dilutive financingNYSE:LRP
06/07/200707:39PR Newswire (US)Lorus Therapeutics announces revised closing date for proposed plan of arrangementNYSE:LRP
19/06/200723:30PR Newswire (US)Lorus Therapeutics announces the initiation of a clinical trial of GTI-2040 in acute leukemia and myelodysplastic syndromeNYSE:LRP
14/05/200723:30PR Newswire (US)Lorus announces presentation of corporate overview at the Acumen Biofin Rodman & Renshaw 4th Annual Global Healthcare ConferenceNYSE:LRP
02/05/200712:59PR Newswire (US)Lorus Therapeutics announces reorganization resulting in approximately $7,800,000 of non-dilutive financingNYSE:LRP
19/04/200723:30PR Newswire (US)Lorus Therapeutics reports third quarter results for fiscal year 2007NYSE:LRP
17/04/200723:30PR Newswire (US)Lorus Therapeutics Announces Scientific Presentations for Lead Antisense and siRNA Drug Candidates at International Cancer ConfeNYSE:LRP
02/03/200700:00PR Newswire (US)Lorus Therapeutics Announces a Key Scientific Publication on Therapeutic siRNA in Cancer TherapyNYSE:LRP
29/12/200623:00PR Newswire (US)Lorus Therapeutics reports second quarter results for fiscal year 2007NYSE:LRP
07/11/200602:04PR Newswire (US)Lorus announces presentation of corporate overview at the Rodman and Renshaw 8th Annual Healthcare ConferenceNYSE:LRP
01/11/200623:00PR Newswire (US)Lorus Therapeutics announces presentation on GTI-2040 uptake by tumor cells in acute myeloid leukemiaNYSE:LRP
 Showing the most relevant articles for your search:NYSE:LRP

Your Recent History

BIT
UC4CSF
Unicredit Bank
TSXV
LOK.H
LSE
XKSD
Xkorea $
COIN
RATUSD
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved